US Bancorp
PTX

US Bancorp’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

US Bancorp’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,409
Closed -$15K – 3732
2016
Q1 		$15K Hold
1,409
– – ﹤0.01% 2884
2015
Q4 		$42K Buy
1,409
+216
+18% +$6.53K ﹤0.01% 2526
2015
Q3 		$38K Sell
1,193
-210
-15% -$10K ﹤0.01% 2600
2015
Q2 		$83K Sell
1,403
-1,185
-46% -$83.6K ﹤0.01% 2270
2015
Q1 		$276K Buy
2,588
+299
+13% +$28.5K ﹤0.01% 1644
2014
Q4 		$215K Buy
2,289
+422
+23% +$40.3K ﹤0.01% 1732
2014
Q3 		$143K Buy
1,867
+32
+2% +$2.52K ﹤0.01% 1925
2014
Q2 		$165K Buy
+1,835
New +$112K ﹤0.01% 1886

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

US Bancorp's PTX Position: Q2 2016 in Review

US Bancorp sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 1,409 shares — an estimated $15K sold.

US Bancorp first reported a position in PTX in Q2 2014 and held it in 8 quarters. The position peaked at $276K in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • US Bancorp reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • US Bancorp sold 1,409 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $15K.
  • US Bancorp first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 8 quarters.
  • US Bancorp's Pernix Therapeutics Holdings, Inc. position peaked at $276K in Q1 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on US Bancorp's 13F filing for Q2 2016, filed 10 Aug 2016.